Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
WEAV
|
Blake G Modersitzki |
SELL
Open market or private sale
|
Indirect | 59,964 Reduced 0.0% |
$990,005
$16.51 p/Share
|
Jan 30
2025 |
|
HOPE
|
Thomas Stenger
SEVP, Chief Risk Officer |
SELL
Open market or private sale
|
Direct | 4,185 Reduced 17.84% |
$49,508
$11.83 p/Share
|
Jan 30
2025 |
|
PLXS
|
Angelo Michael Ninivaggi Jr
Exec VP, CAO, Gen Coun & Secy |
SELL
Open market or private sale
|
Direct | 3,423 Reduced 10.4% |
$498,388
$145.6 p/Share
|
Jan 30
2025 |
|
ABT
|
Hubert L Allen
EXECUTIVE VICE PRESIDENT |
SELL
Open market or private sale
|
Direct | 58,428 Reduced 24.02% |
$7,482,873
$128.07 p/Share
|
Jan 30
2025 |
|
NPCE
|
Martha Morrell
CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct | 200 Reduced 0.23% |
$3,000
$15.0 p/Share
|
Jan 30
2025 |
|
BENF
|
Jeff Welday
Officer |
SELL
Open market or private sale
|
Direct | 306 Reduced 0.2% |
$189
$0.62 p/Share
|
Jan 30
2025 |
|
CDXS
|
Opaleye Management Inc.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 20,000 Added 0.0% |
$89,800
$4.49 p/Share
|
Jan 30
2025 |
|
ABT
|
Daniel Gesua Sive Salvadori
EXECUTIVE VICE PRESIDENT |
SELL
Open market or private sale
|
Direct | 23,771 Reduced 15.9% |
$3,054,573
$128.5 p/Share
|
Jan 30
2025 |
|
NTRS
|
Jason J. Tyler
President/Wealth Management |
SELL
Open market or private sale
|
Direct | 2,237 Reduced 3.69% |
$252,042
$112.67 p/Share
|
Jan 30
2025 |
|
AUBN
|
David E Housel |
BUY
Open market or private purchase
|
Direct | 200 Added 2.4% |
$4,384
$21.92 p/Share
|
Jan 30
2025 |
|
ALK
|
Andrea L Schneider
SVP PEOPLE |
SELL
Open market or private sale
|
Direct | 1,830 Reduced 8.27% |
$134,175
$73.32 p/Share
|
Jan 30
2025 |
|
TEAM
|
Michael Cannon Brookes
CEO, Co-Founder |
SELL
Open market or private sale
|
Indirect | 7,948 Reduced 0.0% |
$2,120,049
$266.74 p/Share
|
Jan 30
2025 |
|
TEAM
|
Scott Farquhar |
SELL
Open market or private sale
|
Indirect | 7,948 Reduced 0.0% |
$2,120,049
$266.74 p/Share
|
Jan 30
2025 |
|
TDUP
|
Patricia Nakache |
SELL
Open market or private sale
|
Indirect | 79,223 Reduced 0.0% |
$175,082
$2.21 p/Share
|
Jan 30
2025 |
|
BLK
|
J. Richard Kushel
Senior Managing Director |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 12.75% |
$10,727,600
$1072.76 p/Share
|
Jan 30
2025 |
|
SANM
|
Eugene A Delaney
Director |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 11.48% |
$835,000
$83.5 p/Share
|
Jan 30
2025 |
|
MTACW
|
Mary T Szela
CEO AND PRESIDENT |
BUY
Open market or private purchase
|
Direct | 5,010 Added 1.12% |
$26,452
$5.28 p/Share
|
Jan 30
2025 |
|
IBEX
|
Mohammedulla Khaishgi
Director |
SELL
Open market or private sale
|
Direct | 12,600 Reduced 5.84% |
$283,626
$22.51 p/Share
|
Jan 30
2025 |
|
IBEX
|
Mohammedulla Khaishgi
Director |
SELL
Open market or private sale
|
Indirect | 10,000 Reduced 0.0% |
$225,100
$22.51 p/Share
|
Jan 30
2025 |
|
RYAN
|
Nicholas Dominic Cortezi
Director |
SELL
Open market or private sale
|
Indirect | 8,549 Reduced 0.0% |
$567,055
$66.33 p/Share
|
Jan 30
2025 |
|
AGBAR
|
Robert E. Diamond Jr. |
SELL
Open market or private sale
|
Indirect | 10,000 Reduced 0.0% |
$19,000
$1.9 p/Share
|
Jan 30
2025 |
|
FFIV
|
Marianne Budnik
Director |
SELL
Open market or private sale
|
Direct | 728 Reduced 29.14% |
$221,639
$304.45 p/Share
|
Jan 30
2025 |
|
OTLC
|
Vuong Trieu
CHAIRMAN AND CEO |
BUY
Open market or private purchase
|
Direct | 100,003 Added 0.11% |
$3,000
$0.03 p/Share
|
Jan 30
2025 |
|
RGLS
|
David Baltimore |
BUY
Open market or private purchase
|
Direct | 19,610 Added 46.94% |
$20,786
$1.06 p/Share
|
Jan 30
2025 |
|
RGLS
|
Joseph P Hagan
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 50,000 Added 16.09% |
$54,500
$1.09 p/Share
|
Jan 30
2025 |
|
OCX
|
Patrick W Smith
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 318 Added 0.0% |
$639
$2.01 p/Share
|
Jan 30
2025 |
|
DHR
|
Brian W Ellis
Senior Vice President - GC |
SELL
Open market or private sale
|
Direct | 5,700 Reduced 21.98% |
$1,277,541
$224.13 p/Share
|
Jan 30
2025 |
|
NAMS
|
Douglas F Kling
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 13,578 Reduced 23.58% |
-
|
Jan 30
2025 |
|
DBVT
|
Pharis Mohideen
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 600 Reduced 0.54% |
$510
$0.85 p/Share
|
Jan 30
2025 |
|
HGTY
|
Robert I Kauffman
Director |
SELL
Open market or private sale
|
Indirect | 2,643 Reduced 0.0% |
$25,689
$9.72 p/Share
|
Jan 30
2025 |
|
CMRX
|
David Jakeman
VP OF FINANCE AND ACCOUNTING |
SELL
Open market or private sale
|
Direct | 2,800 Reduced 1.84% |
$11,479
$4.1 p/Share
|
Jan 30
2025 |
|
TBTC
|
Andrew Berger |
BUY
Open market or private purchase
|
Direct | 13,000 Added 24.53% |
$47,320
$3.64 p/Share
|
Jan 30
2025 |
|
CMRX
|
Michael T. Andriole
PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct | 2,350 Reduced 0.38% |
$9,635
$4.1 p/Share
|
Jan 30
2025 |
|
CMRX
|
Michelle La Spaluto
CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 1,015 Reduced 0.58% |
$4,171
$4.11 p/Share
|
Jan 30
2025 |
|
INSM
|
Orlov S Nicole Schaeffer
Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct | 91,140 Reduced 48.42% |
$7,291,200
$80.0 p/Share
|
Jan 30
2025 |
|
TER
|
Sanjay Mehta
VP and Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 614 Reduced 1.98% |
$62,628
$102.0 p/Share
|
Jan 30
2025 |
|
TER
|
Ryan Driscoll
VP, General Counsel, Secretary |
SELL
Open market or private sale
|
Direct | 437 Reduced 9.2% |
$44,574
$102.0 p/Share
|
Jan 30
2025 |
|
LNN
|
Randy A Wood
President and CEO |
SELL
Open market or private sale
|
Direct | 7,649 Reduced 17.62% |
$1,037,204
$135.6 p/Share
|
Jan 30
2025 |
|
CLXT
|
Gerhard Prante
Director |
SELL
Open market or private sale
|
Direct | 1,150 Reduced 3.89% |
$2,829
$2.46 p/Share
|
Jan 30
2025 |
|
BPOP
|
Eli Sepulveda
Executive Vice President |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 24.28% |
$1,050,700
$105.07 p/Share
|
Jan 30
2025 |
|
CHWY
|
Sumit Singh
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 9,285 Reduced 1.86% |
$371,400
$40.0 p/Share
|
Jan 30
2025 |
|
BPOP
|
Eduardo J. Negron
Executive Vice President |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 23.33% |
$1,040,200
$104.02 p/Share
|
Jan 30
2025 |
|
PKI
|
Joel S Goldberg |
SELL
Open market or private sale
|
Direct | 15,170 Reduced 31.23% |
$1,915,667
$126.28 p/Share
|
Jan 30
2025 |
|
CHWY
|
Satish Mehta
Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 83,639 Reduced 20.02% |
$3,345,560
$40.0 p/Share
|
Jan 30
2025 |
|
SMBC
|
Douglas Bagby |
SELL
Open market or private sale
|
Direct | 7,000 Reduced 25.0% |
$413,560
$59.08 p/Share
|
Jan 30
2025 |
|
GLW
|
Michael Alan Bell |
SELL
Open market or private sale
|
Direct | 2,209 Reduced 100.0% |
$110,162
$49.87 p/Share
|
Jan 30
2025 |
|
NWFL
|
Ronald R Schmalzle |
BUY
Open market or private purchase
|
Direct | 2,000 Added 10.19% |
$52,000
$26.0 p/Share
|
Jan 30
2025 |
|
CBIO
|
Songjiang Ma
President |
SELL
Open market or private sale
|
Indirect | 2,000 Reduced 0.0% |
$22,740
$11.37 p/Share
|
Jan 30
2025 |
|
KFS
|
John Taylor Maloney Fitzgerald
President and CEO |
BUY
Open market or private purchase
|
Direct | 300 Added 0.02% |
$2,499
$8.33 p/Share
|
Jan 30
2025 |
|
KFS
|
Kent A Hansen
CFO & EVP |
BUY
Open market or private purchase
|
Direct | 37 Added 0.03% |
$308
$8.33 p/Share
|
Jan 30
2025 |